Growth Mixture Modeling (GMM) to Determine Treatment Effects of Canagliflozin Versus Sitagliptin on Weight-Related Quality of Life (WRQoL) in Subjects with Type 2 Diabetes Mellitus (T2DM)
Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.715
https://www.valueinhealthjournal.com/article/S1098-3015(13)02620-X/fulltext
Title :
Growth Mixture Modeling (GMM) to Determine Treatment Effects of Canagliflozin Versus Sitagliptin on Weight-Related Quality of Life (WRQoL) in Subjects with Type 2 Diabetes Mellitus (T2DM)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)02620-X&doi=10.1016/j.jval.2013.08.715
First page :
A447
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
686